Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Zynerba Pharma CS (ZYNE)

11.14 -0.22 (-1.94%)

02-16 16:00

Open:

11.36

Pre. Close:

11.36

High:

11.5

Low:

11.051

Volume:

176,784

Market Cap:

151M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

11.512 - 11.575

11.575 - 11.627

Low:

10.899 - 10.977

10.977 - 11.041

Close:

11.023 - 11.141

11.141 - 11.24

Technical analysis  (as of: 2018-02-16 4:26:58 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 13.97     One year: 15.16

Support:

Support1: 10.32    Support2: 8.59

Resistance:

Resistance1: 11.96    Resistance2: 12.98

Pivot:

11.52

Moving Averages:

MA(5): 11.36     MA(20): 11.54

MA(100): 11.40     MA(250): 14.43

MACD:

MACD(12,26): -0.18     Signal(12,26,9): -0.18

%K %D:

%K(14,3): 37.97     %D(3): 40.43

RSI:

RSI(14): 43.50

52-Week:

High: 25.95  Low: 5.42  Change(%): -48.1

Average Vol(K):

3-Month: 34900  10-Days 23596

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ZYNE has closed above bottom band by 32.6%. Bollinger Bands are 29.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 13 Feb 2018 11:37:30 GMT
Should You Buy Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Now?

Tue, 01 Aug 2017 11:26:15 GMT
Zynerba Pharmaceuticals Reports Second Quarter 2017 Financial Results and ...

Tue, 23 Jan 2018 00:00:00 GMT
Why Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) Is A Financially Healthy Company

Mon, 07 Aug 2017 12:06:24 GMT
Zynerba Pharma shares plummet 53% on failed trial for cannabidiol gel in epilepsy

Fri, 16 Feb 2018 11:13:44 GMT
Why Technical Analysis Matters on Zynerba Pharmaceuticals, Inc. (ZYNE)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

13.55

Shares Float (M)

11.49

% Held by Insiders

% Held by Institutions

30.20

Shares Short (K)

2240

Shares Short Prior Month (K)

2790

Stock Financials

EPS

EPS Est. Current Year

-2.420

EPS Est. Next Year

-2.390

EPS Est. Next Quarter

-0.580

Forward EPS

-2.691

Book Value (p.s.)

2.360

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-55.5

Return on Equity (ttm)

-63.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-24.64

Levered Free Cash Flow (M)

-13.83

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

4.72

P/S

P/CF

-6.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.